Skip to content

Lawrence A. Leiter

Brigham and Women's Hospital

2 papers in the Anchorcite directory, published between 2016 and 2018, cited 13,790 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Steven P. Marso · 1 paper
  • Stephen Charles Bain · 1 paper
  • Agostino Consoli · 1 paper
  • Freddy Goldberg Eliaschewitz · 1 paper
  • Esteban Jódar · 1 paper
  • Ildiko Lingvay · 1 paper
  • Julio Rosenstock · 1 paper
  • Jochen Seufert · 1 paper

Papers

  1. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine · 2016 · 7,190 citations

    BACKGROUND: Establishing cardiovascular safety of new therapies for type 2 diabetes is important. Safety data are available for the subcutaneous form of the glucagon-like peptide-1 receptor agonist semaglutide but are needed for oral semaglutide. METHODS: We assessed cardiovascular outcomes of…

  2. Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesNew England Journal of Medicine · 2018 · 6,600 citations

    BACKGROUND: The cardiovascular safety profile of dapagliflozin, a selective inhibitor of sodium-glucose cotransporter 2 that promotes glucosuria in patients with type 2 diabetes, is undefined. METHODS: of body-surface area, new end-stage renal disease, or death from renal or cardiovascular causes)…

Metadata from OpenAlex (CC0).